Compare MNDR & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MNDR | VVOS |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6M | 17.7M |
| IPO Year | 2024 | 2020 |
| Metric | MNDR | VVOS |
|---|---|---|
| Price | $1.03 | $2.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | ★ 167.5K | 129.8K |
| Earning Date | 10-31-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,646,739.00 | ★ $17,317,000.00 |
| Revenue This Year | $608,852.40 | $17.96 |
| Revenue Next Year | N/A | $55.64 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18.76 |
| 52 Week Low | $0.83 | $1.93 |
| 52 Week High | $40.00 | $7.95 |
| Indicator | MNDR | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 40.32 | 51.08 |
| Support Level | $0.91 | $1.94 |
| Resistance Level | $1.03 | $2.69 |
| Average True Range (ATR) | 0.09 | 0.14 |
| MACD | 0.04 | 0.05 |
| Stochastic Oscillator | 44.78 | 38.67 |
Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services, and the Sale of medicine and medical devices. The majority of the company's revenue is derived from the Telemedicine and other services segment. Geographically, it derives revenue from Singapore.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.